The “Safer” Blood That Isn’t

Families who request directed donation from an “unvaccinated” donor believe they are choosing the safer option. The literature says the opposite. Directed donations, particularly from first time donors recruited specifically for the occasion, carry higher rates of infectious disease marker reactivity than units from repeat community donors. The donor pool people trust the most, because they know the person, is measurably less safe than the anonymous pool they're trying to avoid.

That paradox sat quietly in the guidelines for years, cited in position statements and discouraged in policy language, without much data on what actually happens when a request like this proceeds anyway. A two year single center series out of Vanderbilt, published this year in Transfusion, gives us that data. It's worth sitting with.

What They Found

Between January 2024 and December 2025, the VUMC blood bank received 144,856 total blood product units. Of those, 48, or 0.03 percent, were directed donor units collected specifically because a patient or family refused standard inventory over concerns about vaccinated donors. Every single directed donation in the study period, with no exceptions for rare blood types or other medically recognized indications, was motivated by this concern.

Those 48 units covered 15 patients. Median age was 17, ranging from 4 months to 73 years, and 60 percent were pediatric. The requests weren't rare and holding steady either. They climbed from 4 patients in 2024 to 11 in 2025.

Thirteen of the 15 patients were transfused at least one directed unit. And 7 of the 15, nearly half, had at least one unit collected on their behalf that was never actually transfused to them. Those units didn't vanish. Most were released back into general inventory. Someone drew blood from a specific person, for a specific patient, under a specific belief about safety, and then that blood went to a stranger anyway. That's not a rare edge case in this series. It's closer to the norm.

Where the System Broke

Here is the finding that matters most to me as a transfusion medicine physician: of the 15 cases, only 1 had a documented ethics consultation. Only 1 had transfusion medicine notified before the directed unit arrived at the blood bank, and even that notification came after the perioperative service had already approved the request going forward.

This isn't a story about families making an uninformed choice in a vacuum. It's a story about a workflow. Requests here were routed directly from a family or a primary clinical team to an external blood donor center's online form, entirely outside the consultation structure that exists precisely to handle requests this ethically and medically complicated. By the time anyone with transfusion medicine expertise heard about it, the decision had usually already been made.

It didn't have to go this way. Mayo Clinic's Bloodless Medicine and Surgery Program uses structured shared decision making for exactly this kind of request, and most families end up accepting standard blood products through that process. Mayo has since restricted directed donation absent a genuine medical indication. Seattle Children's Hospital built a similar structured consultation model, pairing transfusion medicine with ethics, for pediatric cardiac surgery cases with vaccine related concerns, and it worked there too. The difference between those institutions and this series isn't the families. It's whether anyone with the right expertise was in the room before the blood was drawn.

Harm in Both Directions

The clinical consequences in this series are not abstract. One patient's hemoglobin fell to 5.9 g/dL with symptomatic anemia while transfusion was delayed awaiting arrival of directed units. That same patient later received a transfusion at a hemoglobin of 9.2, a clear deviation from institutional guidelines, because the clinical team didn't want the directed unit to go to waste after all that effort to obtain it.

Sit with that sequence for a second. A patient was harmed by the delay. Then a guideline appropriate threshold was overridden to avoid wasting a unit that should never have been the deciding factor in the first place. The instinct to avoid waste, once the unit exists, quietly overrides the standard of care that exists to protect the patient.

A second patient developed hemodynamic shock with a hemoglobin nadir of 3.6 while awaiting directed blood. Two additional patients had surgery delayed or cancelled entirely because of directed component logistics. Four of fifteen patients, more than a quarter of this small cohort, experienced a documented adverse clinical or operational event tied directly to this workflow.

Outcome	Patients
Received at least one directed unit	15
Transfused at least one directed unit	13 (87%)
Had at least one unit collected but never transfused to them	7 (47%)
Clinical deterioration while awaiting directed units	2 (13%)
Transfusion deviating from institutional guidelines	1 (7%)
Surgical delay or cancellation	2 (13%)
Ethics consultation documented	1 (7%)
Transfusion medicine notified before unit arrival	1 (7%)

The Weight Falls on Children

Nine of the fifteen patients in this series were minors. Among pediatric patients, surrogate decision making applied in 100 percent of cases, compared to 17 percent of adult cases. These are children absorbing the downstream consequences, clinical and logistical, of a belief about vaccination status that they had no part in forming and no ability to consent around. The ethical weight of that imbalance is hard to overstate, and it's the piece of this paper I keep returning to.

A Familiar Failure Mode

I've written before about laboratory medicine as a kind of governance layer, the expert checkpoint that's supposed to sit between a high stakes request and its execution, whether that request involves an unvalidated algorithm or a unit of blood. This series is that same failure mode wearing a different face. An ethically loaded, medically consequential request bypassed the expert consultation layer almost entirely, not because the layer didn't exist, but because the workflow routed around it. Governance failures rarely look like a single bad decision. They look like a form that lets you skip the conversation.

Where This Leaves Us

The authors propose a fix that sounds almost too simple: mandatory transfusion medicine consultation for every directed donation request, before collection proceeds, replacing what is currently an optional and easily bypassed step. Mayo and Seattle Children's suggest that when this consultation happens, most families accept standard products anyway. That's an encouraging signal, but it doesn't fully resolve the harder tension underneath this paper, the one between respecting a family's autonomy to make decisions about their own care and preventing exactly the kind of harm this series documents. A mandatory consult can close the routing gap. It can't, by itself, tell us how to balance those two obligations when a family still says no after hearing everything transfusion medicine has to say.